Long-Term Changes in Hepatic Fibrosis following Hepatitis C Viral Clearance in Patients with and without HIV
Antiviral Therapy2018Vol. 24(6), pp. 451–457
Citations Over TimeTop 19% of 2018 papers
Julia B. Balmaceda, Julia Aepfelbacher, Olivia Belliveau, Chloe S Chaudhury, Cheryl Chairez, Mary McLaughlin, Rachel Silk, Chloe Gross, Sarah Kattakuzhy, Elana Rosenthal, Shyam Kottilil, David E. Kleiner, Colleen Hadigan
Abstract
We identify potentially important relationships between BMI, hepatic steatosis and smoking, and changes in hepatic fibrosis post-SVR in patients with and without HIV coinfection. Attention to modifiable risk factors such as body weight and smoking may reduce the risk of liver disease progression in the growing population of successfully treated chronic HCV patients.
Related Papers
- → How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?(2011)69 cited
- → Assessment of Liver Fibrosis by Transient Elastography in Patients With HIV and Hepatitis B Virus Coinfection in Nigeria(2013)34 cited
- → Can protocol liver biopsy be avoided to evaluate post-transplant hepatitis C recurrence? Transient elastography makes it possible(2009)9 cited
- Transient elastography--an alternative to liver biopsy in patients with chronic hepatitis C?(2007)
- → How Often Does Liver Fibrosis Stage Predicted by Transient Elastography (TE) Differ From the One Diagnosed by Liver Biopsy in Chronic Hepatitis C Patients?(2013)